Patents by Inventor Samuel Shuster

Samuel Shuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for removing abnormal keratinous material
    Patent number: 7476396
    Abstract: The present invention discloses a pharmaceutical method comprising urea, a hydrophilic film-forming agent, water and/or a water-alcohol mixture that is suitable for the removal of abnormal keratinous material.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: January 13, 2009
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Horst Ulbricht, Rainer Pooth, Samuel Shuster
  • Methods and materials for modulating trpm2
    Publication number: 20070021361
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of TRPM2. The compositions comprise antisense oligonucleotides, particularly antisense oligonucleotides targeted to nucleic acids encoding TRPM2.
    Type: Application
    Filed: December 4, 2003
    Publication date: January 25, 2007
    Inventors: Samuel Shuster, Ulf Arvidsson, Laura Stone, Hong-Yan Zhang, Lucy Vulchanova Hart
  • Methods and materials for modulating task-3
    Publication number: 20060246432
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of TASK-3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding TASK-3.
    Type: Application
    Filed: December 31, 2002
    Publication date: November 2, 2006
    Inventors: Samuel Shuster, Laura Stone, Hong-Yan Zhang, Lucy Hart
  • Methods and materials for modulating trpc4
    Publication number: 20060194750
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of TRPC4. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding TRPC4.
    Type: Application
    Filed: December 31, 2002
    Publication date: August 31, 2006
    Inventors: Samuel Shuster, Arvidson Ulf N.G, Laura Stone, Hong-Yan Zhang, Lucy Hart
  • Antisense modulation of purinoreceptor p2x3
    Publication number: 20060116339
    Abstract: The invention relates to antisense oligonucleotides, compositions and methods useful for modulating the expression of P2X3. The compositions comprise antisense oligonucleotides, particularly antisense oligonucleotides targeted to nucleic acids encoding P2X3.
    Type: Application
    Filed: November 8, 2002
    Publication date: June 1, 2006
    Inventors: Samuel Shuster, Ulf Arvidsson, Laura Stone, Hong-Yan Zhang, Lucy Hart
  • Composition for removing abnormal keratinous material
    Publication number: 20040146555
    Abstract: The present invention discloses a pharmaceutical preparation comprising urea, a hydrophilic film-forming agent, water and/or a water-alcohol mixture that is suitable for the removal of abnormal keratinous material.
    Type: Application
    Filed: January 15, 2004
    Publication date: July 29, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Horst Ulbricht, Rainer Pooth, Samuel Shuster
  • Composition for removing abnormal keratinous material
    Publication number: 20020197291
    Abstract: The present invention discloses a pharmaceutical preparation comprising urea, a hydrophilic film-forming agent, water and/or a water-alcohol mixture that is suitable for the removal of abnormal keratinous material.
    Type: Application
    Filed: May 29, 2002
    Publication date: December 26, 2002
    Inventors: Horst Ulbricht, Rainer Pooth, Samuel Shuster